5F-NNE1
5F-NNE1 is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the cannabinoid receptors and has been associated with various adverse effects.
Chemical Structure and Properties
5F-NNE1, also known as 5F-NNEI, is chemically classified as an indazole-based synthetic cannabinoid. Its full chemical name is 1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-indazole-3-carboxamide. The compound features a fluorinated pentyl chain, which is a common modification in synthetic cannabinoids to enhance their potency.
Pharmacology
5F-NNE1 acts as a potent agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including pain sensation, mood, and appetite.
Legal Status
The legal status of 5F-NNE1 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and adverse health effects. For example, in the United States, it is listed as a Schedule I controlled substance under the Controlled Substances Act.
Health Effects and Risks
The use of 5F-NNE1 has been associated with a range of adverse health effects. These can include tachycardia, hypertension, nausea, vomiting, and psychosis. Due to its high potency, there is a significant risk of overdose, which can lead to severe health complications or death.
Detection in Biological Samples
5F-NNE1 can be detected in biological samples using various analytical techniques such as gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). These methods are commonly used in forensic and clinical toxicology to identify the presence of synthetic cannabinoids.
Regulation and Control
Due to the health risks associated with synthetic cannabinoids like 5F-NNE1, many countries have implemented strict regulations to control their distribution and use. These regulations aim to reduce the prevalence of these substances and mitigate their impact on public health.
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD